Help clients understand what is happening in the market, where science is leading us and enable next-level personalization through approaches like pharmacogenomics, the study of how genes affect a person's response to drugs.

Richard Adams, Forbes, 6 May 2021

“Genomics is even changing the way we develop drugs,”

“It’s much more sophisticated because we can find a specific alteration that is causing a disease and try to target a medicine specifically to that alteration.”

“Traditionally, health care’s approach has been a bit general,”

“Now we can look at a disease on a personal level.”

Kemal Malik, member of the Bayer board of management responsible for innovation